Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 0 22 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 0 22 IN DEXTROSE 10 AND SODIUM CHLORIDE 0 2 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE vs POTASSIUM CHLORIDE 0.22% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Potassium is the major intracellular cation, essential for maintaining cell membrane potential, nerve impulse transmission, muscle contraction, and acid-base balance. Dextrose provides caloric supplementation. Sodium chloride provides sodium and chloride ions for electrolyte balance.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
Intravenous infusion. Adult dose is determined by fluid, electrolyte, and caloric requirements. Typically, 1000-3000 mL per day at a rate of 125-150 mL/hour, providing 0.22% KCl (2 mEq/L), 10% dextrose, and 0.2% NaCl (34 mEq/L Na+). Adjust based on serum potassium and glucose monitoring.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateTerminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Not applicable as potassium chloride is an electrolyte; elimination follows first-order kinetics with a distribution half-life of ~8-10 minutes; plasma levels depend on infusion rate and renal function.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Renal: >90% as potassium and chloride ions, with potassium excretion primarily via distal tubular secretion and reabsorption; minimal fecal or biliary elimination.
Category C
Category A/B
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."